康臣药业(01681)12月12日斥资343.73万港元回购23.1万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Share Buyback Details - The company plans to repurchase 231,000 shares at a total cost of HKD 3.4373 million [1] - The buyback price per share ranges from HKD 14.76 to HKD 14.97 [1]